We have previously reported that MNTX inhibits opioid and VEGF-induced Akt activation in human endothelial cells and that overexpression of MOR in human NSCLC activates Akt [4], [13], [62], [63]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.